Who owns VIRACTA THERAPEUTICS INC?
- Ticker: VIRX
- CUSIP Number: 92765f108
Tip: Access positions for across all investors
Analyze quarterly positions in Viracta Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Viracta Therapeutics stock
Who bought or sold VIRACTA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 3.6M | $3.7M | 0% | Mar 2024 |
|
| Citadel Advisors | 1.6M | $1.6M | 3% | Mar 2024 |
|
| Vanguard Group | 1.2M | $1.2M | 0% | Mar 2024 |
|
| Samsara BioCapital | 690k | $704k | 0% | Mar 2024 |
|
| Laurion Capital Management | 420k | $429k | -25% | Mar 2024 |
|
| MAI Wealth Advisors | 364k | $371k | 2% | Mar 2024 |
|
| BlackRock | 304k | $310k | -1% | Mar 2024 |
|
| Aisling Capital Management | 289k | $165k | 0% | Dec 2023 |
|
| Geode Capital Management | 253k | $258k | 0% | Mar 2024 |
|
| Morgan Stanley | 118k | $120k | 96% | Mar 2024 |
|
| Bridgeway Capital Management | 74k | $76k | 0% | Mar 2024 |
|
| Ensign Peak Advisors | 63k | $65k | 0% | Mar 2024 |
|
| Northern Trust | 38k | $39k | 5% | Mar 2024 |
|
| United Bank | 25k | $26k | 0% | Mar 2024 |
|
| XTX Topco | 17k | $17k | 41% | Mar 2024 |
|
| Integrys Wealth Advisors | 15k | $15k | 50% | Mar 2024 |
|
| HoyleCohen | 14k | $8.0k | 0% | Dec 2023 |
|
| Trust Co Of Toledo Na | 12k | $13k | 0% | Mar 2024 |
|
| Bank of America Corporation | 12k | $13k | 52% | Mar 2024 |
|
| Wealthtrust Axiom | 11k | $12k | 100% | Mar 2024 |
|
| Acadian Asset Management | 11k | $11k | -89% | Mar 2024 |
|
| Tower Research Capital | 8.9k | $9.1k | 76% | Mar 2024 |
|
| Planning Capital Management Corp | 7.3k | $7.4k | 0% | Mar 2024 |
|
| Simplex Trading | 4.9k | $4.0k | 100% | Mar 2024 |
|
| RP Management | 3.7k | $3.8k | 0% | Mar 2024 |
|
| IAG Wealth Partners | 3.0k | $3.1k | 0% | Mar 2024 |
|
| Barclays | 2.7k | $3.0k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 2.1k | $0 | -80% | Mar 2024 |
|
| Nbc Securities | 1.4k | $1.0k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 721.00 | $734.987400 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 385.00 | $391.737500 | 1% | Mar 2024 |
|
| Indiana Trust & Investment Management | 200.00 | $204.000000 | 0% | Mar 2024 |
|
| UBS Group | 95.00 | $97.004500 | -100% | Mar 2024 |
|
| Goss Wealth Management | 14.00 | $14.000000 | 0% | Mar 2024 |
|
| Parallel Advisors | 8.00 | $8.000000 | 0% | Mar 2024 |
|
| Addison Advisors | 4.00 | $5.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 2.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Viracta Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Dec 2023 | 36k | $21k |
| Virtu Financial | Dec 2023 | 27k | $16k |
| Two Sigma Securities | Dec 2023 | 16k | $8.9k |
| Bourgeon Capital Management | Dec 2023 | 7.5k | $4.3k |
| Private Ocean | Dec 2023 | 3.00 | $2.000100 |